Results 241 to 250 of about 12,288 (265)

Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine

Journal of the European Academy of Dermatology and Venereology, 2022
We reported the 5 published case of COVID-19 vaccine inducing SS and the first case to be induced by an inactivated SARS-CoV-2 vaccine « CoronaVac ». The short latency time strongly supports the pathogenic role of the vaccine as a cause of SS in our case.
Ben Salah Nesrine, Mouna Korbi, Najeh Ben Fadhel, Idoudi Safa, Ferdaous Chahed, Manel Njima, Hichem Belhadjali, Montassar Amri, Karim Aouam, Jameleddine Zili   +9 more
openaire   +2 more sources

Alopecia areata after CoronaVac vaccination

Journal of Cosmetic Dermatology, 2022
Miguel Aristizabal, Jeffery T. S. Hsu, Michael H. Gold   +2 more
openaire   +2 more sources

CoronaVac Progress Update

2020
Syafiq, Ahmad, Bahrian, Juan Dennis
openaire   +1 more source

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Lancet, The, 2021
Mine Durusu Tanriover, Hamdi Levent Doganay, Murat Akova   +2 more
exaly  

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Lancet, The, 2022
Sue Ann Costa Clemens, Ralf Clemens, Bruno Solano de Freitas Souza   +2 more
exaly  

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

Nature Medicine, 2022
Eddy N Pérez-Then, Carolina Lucas, Valter Vinicius Silva Monteiro   +2 more
exaly  

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature Medicine, 2022
Chris Ka Pun Mok, Eric Ho-Yin Lau, Leo Lit Man Poon   +2 more
exaly  

Cutaneous diseases developed following BNT162b2 and CoronaVac vaccines

2023
Although the safety of severe acute respiratory syndrome coronavirus 2 vaccines was demonstrated in clinical trials, some adverse events were also reported after their routine use. In this study, the delayed cutaneous reactions that developed after BNT162b2 and CoronaVac vaccines are reported.
openaire   +1 more source

Antibodies Response in CKD Patients Vaccinated With CoronaVac

Journal of the American Society of Nephrology, 2022
Catarina Minczuk, Fernando L. Fonseca, Vitor Augusto Q. Mauad, Marcelo R. Bacci   +3 more
openaire   +1 more source